Pharmanex is a division of Nu Skin Enterprises (NUS), a debt free billion-dollar enterprise, and is publicly traded on the New York Stock Exchange. NSE/PX has $170 million in cash reserves, 3 multi-million dollar labratories, $600 million in assets and the highest credit rating available; a 5A1 Dunn & Bradstreet rating. Click here to review historical income statement and balance sheet data.
Nu Skin Enterprises is a leading direct-selling company that distributes premium quality products and services through three core business opportunities - Nu Skin, Pharmanex and Big Planet
Pharmanex Division
With a team of more than 125 scientists, Pharmanex uses a pharmaceutical approach to set the industry standard in dietary supplements. Revenues in 2004 grew 20 percent to $567.2 million.
Nu Skin Division
Generated $548.1 million in revenue in 2004 with a line of more than 100 premium skin treatment and other personal care products.
Big Planet Division
Big Planet brings the benefits of technology to everyone. Revenues in 2004 were $22.6 million.
Markets
Nu Skin Enterprises is a global corporation, conducting business in 40 markets worldwide. In 2004, approximately 84 percent of revenues were generated from markets in Asia.
Nu Skin Force for Good Foundation
Nu Skin Enterprises also runs a non-profit humanitarian organization called the Nu Skin Force for Good Foundation. The foundation's mission is to create a better world for children by improving human life, continuing indigenous cultures and protecting fragile environments.
Virtual Tour of Corporate Offices